Orion traded at 35.76 this Friday May 13th, increasing 0.22 or 0.62 percent since the previous trading session. Looking back, over the last four weeks, Orion gained 15.00 percent. Over the last 12 months, its price fell by 2.40 percent. Looking ahead, we forecast Orion to be priced at 34.57 by the end of this quarter and at 31.23 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
Daily Change

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Peers Price Day Year
Almirall SA 10.44 0.05 0.48% -27.04%
Hikma Pharmaceutical 1,716.00 19.00 1.12% -25.84%
H Lundbeck A/S 166.80 7.30 4.58% -17.95%
Oriola-kd 2.02 0.04 2.18% 9.39%
Raisio Oyj 2.05 0.03 1.23% -49.26%
Recordati 41.22 1.32 3.31% -6.74%
UCB 89.92 -11.98 -11.76% 16.21%

Indexes Price Day Year
Helsinki 10823 -38.47 -0.35% -9.64%
Helsinki 25 4726 -20.22 -0.43% -8.33%

Orion Oyj, previously Orion Corporation, is a Finland-based company active within the pharmaceutical industry. The Company is engaged in the research and development, manufacture and marketing of human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of the Company's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory diseases.